Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)

Main Article Content

Jonathan I Silverberg
Weily Soong
Benjamin Lockshin
Abhijit Gadkari
Zhen Chen
Ashish Bansal

Keywords

Atopic Dermatitis, Biologics, Dupilimab, Mental Health, Anxiety, Depression

Abstract

Abstract not available.

References

1. Weidinger S, Novak N. Lancet. 2016;387:1109-22.

2. Yu SH, Silverberg JI. J Invest Dermatol. 2015;135:3183-6.

3. Eckert L, et al. J Am Acad Dermatol. 2017;77:274-9.

4. Silverberg JI, et al. J Invest Dermatol. 2019;139:1388-91.

5. Macdonald LE, et al. Proc Natl Acad Sci U S A. 2014;111:5147-52.

6. Murphy AJ, et al. Proc Natl Acad Sci U S A. 2014;111:5153-8.

7. Gandhi NA, et al. Nat Rev Drug Discov. 2016;15:35-50.

8. Gandhi NA, et al. Expert Rev Clin Immunol. 2017;13:425-37.

9. Simpson EL, et al. N Engl J Med. 2016;375:2335-48.

10. Simpson EL, et al. JAMA Derm. 2019; Nov 6 [Epub ahead of print]. doi: https://doi.org/10.1001/jamadermatol.2019.3336.

Most read articles by the same author(s)

1 2 3 > >>